| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 27 |
| 1 | ERGOCALCIFEROL | 21 |
| 2 | ETANERCEPT | 20 |
| 3 | METHOTREXATE SODIUM | 19 |
| 4 | ADALIMUMAB | 16 |
| 5 | LEFLUNOMIDE | 16 |
| 6 | METHOTREXATE | 16 |
| 7 | RUXOLITINIB | 14 |
| 8 | TOFACITINIB | 14 |
| 9 | ALPRAZOLAM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 4 | 0.0022 |
| 1 | PROPAFENONE | 9 | 0.0021 |
| 2 | METHENAMINE HIPPURATE | 2 | 0.0016 |
| 3 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 4 | THEOPHYLLINE ANHYDROUS | 9 | 0.0007 |
| 5 | ERGOCALCIFEROL | 21 | 0.0007 |
| 6 | EPLERENONE | 9 | 0.0007 |
| 7 | INCLISIRAN | 5 | 0.0006 |
| 8 | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 0.0005 |
| 9 | HYDROCORTISONE SODIUM SUCCINATE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 2 | Provitamin D2 Compound [EPC] | 21 |
| 3 | Kinase Inhibitor [EPC] | 19 |
| 4 | Antirheumatic Agent [EPC] | 16 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 6 | Janus Kinase Inhibitor [EPC] | 15 |
| 7 | Benzodiazepine [EPC] | 14 |
| 8 | Factor Xa Inhibitor [EPC] | 14 |
| 9 | Loop Diuretic [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Provitamin D2 Compound [EPC] | 21 | 0.0007 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 4 | Complement Inhibitor [EPC] | 12 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 11 | 0.0002 |
| 7 | Bile Acid [EPC] | 4 | 0.0002 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Methylxanthine [EPC] | 9 | 0.0002 |